Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychedelic drug
Biotech
FDA advisers to weigh first psychedelic therapy in early June
Lykos Therapeutics’ MDMA-assisted therapy is charting yet another first in the psychedelic field: an FDA advisory meeting.
Max Bayer
May 7, 2024 11:10am
Reunion nets $103M, one of the largest for a psychedelic biotech
May 2, 2024 6:30am
Mindstate takes trip to clinic with first AI-derived psychedelic
Mar 13, 2024 9:00am
JPM's private capital team ‘actively looking’ at psychedelics
Feb 28, 2024 7:00am
Psychedelic biotech MAPS PBC rebrands to Lykos, snags $100M
Jan 5, 2024 10:50am
Compass shows safety in first psilocybin trial for PTSD
Dec 20, 2023 7:26am